PMID- 28732392 OWN - NLM STAT- MEDLINE DCOM- 20180718 LR - 20220321 IS - 1438-8812 (Electronic) IS - 0013-726X (Linking) VI - 49 IP - 12 DP - 2017 Dec TI - Systematic assessment with I-SCAN magnification endoscopy and acetic acid improves dysplasia detection in patients with Barrett's esophagus. PG - 1219-1228 LID - 10.1055/s-0043-113441 [doi] AB - Background and study aims Enhanced endoscopic imaging with chromoendoscopy may improve dysplasia recognition in patients undergoing assessment of Barrett's esophagus (BE). This may reduce the need for random biopsies to detect more dysplasia. The aim of this study was to assess the effect of magnification endoscopy with I-SCAN (Pentax, Tokyo, Japan) and acetic acid (ACA) on dysplasia detection in BE using a novel mucosal and vascular classification system. Methods BE segments and suspicious lesions were recorded with high definition white-light and magnification endoscopy enhanced using all I-SCAN modes in combination. We created a novel mucosal and vascular classification system based on similar previously validated classifications for narrow-band imaging (NBI). A total of 27 videos were rated before and after ACA application. Following validation, a further 20 patients had their full endoscopies recorded and analyzed to model use of the system to detect dysplasia in a routine clinical scenario. Results The accuracy of the I-SCAN classification system for BE dysplasia improved with I-SCAN magnification from 69 % to 79 % post-ACA (P = 0.01). In the routine clinical scenario model in 20 new patients, accuracy of dysplasia detection increased from 76 % using a "pull-through" alone to 83 % when ACA and magnification endoscopy were combined (P = 0.047). Overall interobserver agreement between experts for dysplasia detection was substantial (0.69). Conclusions A new I-SCAN classification system for BE was validated against similar systems for NBI with similar outcomes. When used in combination with magnification and ACA, the classification detected BE dysplasia in clinical practice with good accuracy.Trials registered at ISRCTN (58235785). CI - (c) Georg Thieme Verlag KG Stuttgart . New York. FAU - Lipman, Gideon AU - Lipman G AD - Division of Surgery and Interventional Science, University College London, United Kingdom. AD - Department of Gastroenterology, University College Hospital NHS Foundation Trust, London, United Kingdom. FAU - Bisschops, Raf AU - Bisschops R AD - Universitaire Ziekenhuizen Leuven, Leuven, Belgium. FAU - Sehgal, Vinay AU - Sehgal V AD - Division of Surgery and Interventional Science, University College London, United Kingdom. AD - Department of Gastroenterology, University College Hospital NHS Foundation Trust, London, United Kingdom. FAU - Ortiz-Fernandez-Sordo, Jacobo AU - Ortiz-Fernandez-Sordo J AD - NIHR Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom. FAU - Sweis, Rami AU - Sweis R AD - Department of Gastroenterology, University College Hospital NHS Foundation Trust, London, United Kingdom. FAU - Esteban, Jose M AU - Esteban JM AD - Hospital Clinico San Carlos, Madrid, Spain. FAU - Hamoudi, Rifat AU - Hamoudi R AD - Division of Surgery and Interventional Science, University College London, United Kingdom. AD - Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. FAU - Banks, Matthew R AU - Banks MR AD - Division of Surgery and Interventional Science, University College London, United Kingdom. AD - Department of Gastroenterology, University College Hospital NHS Foundation Trust, London, United Kingdom. FAU - Ragunath, Krish AU - Ragunath K AD - NIHR Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom. FAU - Lovat, Laurence B AU - Lovat LB AD - Division of Surgery and Interventional Science, University College London, United Kingdom. AD - Department of Gastroenterology, University College Hospital NHS Foundation Trust, London, United Kingdom. FAU - Haidry, Rehan J AU - Haidry RJ AD - Division of Surgery and Interventional Science, University College London, United Kingdom. AD - Department of Gastroenterology, University College Hospital NHS Foundation Trust, London, United Kingdom. LA - eng GR - II-FS-0509-12051/DH_/Department of Health/United Kingdom PT - Journal Article PT - Validation Study DEP - 20170721 PL - Germany TA - Endoscopy JT - Endoscopy JID - 0215166 RN - 0 (Indicators and Reagents) RN - Q40Q9N063P (Acetic Acid) SB - IM CIN - Endoscopy. 2017 Dec;49(12):1291-1292. PMID: 29186741 MH - Acetic Acid MH - Aged MH - Aged, 80 and over MH - Barrett Esophagus/*classification/*diagnostic imaging/pathology MH - Endoscopy, Gastrointestinal/*methods MH - Esophageal Mucosa/blood supply/*diagnostic imaging/pathology MH - Female MH - Humans MH - Indicators and Reagents MH - Male MH - Microvessels/diagnostic imaging MH - Middle Aged MH - Observer Variation MH - Reproducibility of Results MH - Sensitivity and Specificity COIS- Competing interests: Dr. Haidry has received research grant support from Pentax Medical, Cook Endoscopy, and Covidien plc to support research infrastructure. Dr. Ragunath has received research grant support from Pentax Medical. EDAT- 2017/07/22 06:00 MHDA- 2018/07/19 06:00 CRDT- 2017/07/22 06:00 PHST- 2017/07/22 06:00 [pubmed] PHST- 2018/07/19 06:00 [medline] PHST- 2017/07/22 06:00 [entrez] AID - 10.1055/s-0043-113441 [doi] PST - ppublish SO - Endoscopy. 2017 Dec;49(12):1219-1228. doi: 10.1055/s-0043-113441. Epub 2017 Jul 21.